Novo Holdings A/S

Q2 2026 13F-HR Holdings

Location
Hellerup, G7
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
25
Total value ($000)
$1,722,217
Net value change ($000)
+488,002 (39.5%)
New positions
6
Sold out positions
3
Turnover %
27.6%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
HEMAB THERAPEUTICS HLDGS INC 153,552 NEW
AVALYN PHARMACEUTICALS INC 127,838 NEW
ASML 63,481 50.6%
MPLT 57,180 76.3%
EWTX 48,846 29.0%
FND 47,310 NEW
ALMS 30,954 NEW
DYN 21,330 NEW
INSM 12,871 NEW
MIRM 9,300 7.6%
Top Reduces (Value $000, Stocks/ETFs)
APGE -37,877 -100.0%
BMRN -37,283 -100.0%
CRM -11,799 -16.1%
BABA -7,586 -23.5%
CRNX -6,902 -12.3%
VALN -6,609 -100.0%
PCVX -3,471 -6.9%
BBOT -2,419 -12.4%
LNZA -1,453 -57.4%
PHVS -1,026 -2.1%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type